Olutasidenib
About
Therapy type: Targeted therapy
Therapy strategy: IDH1 inhibition
Mappings
NCI Thesaurus: Olutasidenib (coding:ncit:C129687)
RxNorm: olutasidenib (coding:rxcui:2623641, coding:omop:742050)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | IDH1 p.R132C | Acute Myeloid Leukemia | Olutasidenib | |
| FDA (1) | IDH1 p.R132G | Acute Myeloid Leukemia | Olutasidenib | |
| FDA (1) | IDH1 p.R132H | Acute Myeloid Leukemia | Olutasidenib | |
| FDA (1) | IDH1 p.R132L | Acute Myeloid Leukemia | Olutasidenib | |
| FDA (1) | IDH1 p.R132S | Acute Myeloid Leukemia | Olutasidenib |